Mutations that substitute methionine for threonine at position 790 (T790M) in the EGFR kinase domain seems to occur in approximately 50% of lung adenocarcinomas from patients with acquired resistance to the EGFR-TKIs [13, 36, 37]. This evidence concerns the gene EGFR and lung adenocarcinoma.